Loading
Latest filing published 30 Jun 2017 for Aptose Biosciences Inc..
No signal scores available.
Only one filing by Mark Vincent is known so far (30 June 2017): an option exercise, in Aptose Biosciences Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.